Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
OR | OR 95% CI | p | OR | OR 95%CI | p | |
Gender (M/F) | 1.77 | 0.97–3.1 | 0.06 | |||
Age at surgery(years) | 1.01 | 0.94–1.02 | 0.94 | |||
BMI (kg/m2) | 0.11 | 0.41–2.7 | 0.55 | |||
Preoperative wt loss (> 10 lb)a | 1.05 | 0.41–2.7 | 0.92 | |||
Disease duration (mos) | 0.99 | 0.99–1.02 | 0.59 | |||
Smoking | ||||||
Never | ||||||
Prior | 0.97 | 0.47–2.0 | 0.97 | |||
Current | 0.67 | 0.79–5.7 | 0.72 | |||
Disease extent | ||||||
E2 Left-sided colitis | ||||||
E3 Pancolitis | 1.45 | 066–3.40 | 0.34 | |||
Disease severity | ||||||
S2 Moderate UC | ||||||
S3 Severe UC | 1.12 | 0.60–2.12 | 0.72 | |||
Disease activity | ||||||
Chronic | ||||||
Acute | 2.83 | 1.05–7.67 | 0.04 | 3.09 | 1.11–8.61 | 0.03 |
Medication history | ||||||
Steroids | 0.92 | 0.59–1.98 | 0.92 | |||
6-MP or MTX | 0.53 | 0.29–0.97 | 0.04 | 0.56 | 0.28–1.07 | 0.08 |
IPAA stages | ||||||
Total abdominal colectomy +end stoma | ||||||
Protectomy + IPAA with ileostomy | 1.24 | 0.65–2.40 | 0.51 | |||
Operation type | ||||||
Open | ||||||
laparoscopy | 0.53 | 0.28–0.98 | 0.04 | 0.54 | 0.27–1.06 | 0.07 |
Preoperative labs | ||||||
Leukocyte (×103/uL) | 1.00 | 1.00–1.00 | 0.45 | |||
Platelet (×103/uL) | 1.01 | 0.99–1.00 | 0.34 | |||
Albumin (g/dL) | 0.82 | 0.40–1.65 | 0.58 | |||
Biologic agent | ||||||
None | ||||||
Anti-TNF | 1.76 | 0.83–3.73 | 0.14 | 2.45 | 1.08–5.59 | 0.03 |
Vedolizumab | 3.15 | 1.08–9.2 | 0.04 | 4.71 | 1.51–14.70 | 0.01 |